Da Silva Jorge Santos, Chief Executive Officer at MoonLake Immunotherapeutics (MLTX), sold 60,000 shares at $60.18 ($3.6M) on 2024-02-15, disclosed to the SEC on 2024-02-20.
Scheduled sale ($3.6M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.18 | 20,000 | $1.2M | 33.9% |
| 2 | $60.15 | 20,000 | $1.2M | 33.8% |
| 3 | $57.44 | 20,000 | $1.1M | 32.3% |
| Total | $59.26 avg | 60,000 | $3.6M | 100% |
| Filing → |
| MLTX | SELL | 2026-04-14 | $2.8M | — | Filing → |
| MLTX | SELL | 2025-12-10 | $3.0M | — | Filing → |
| MLTX | SELL | 2024-02-29 | $7.1M | — | Filing → |